Rchr
J-GLOBAL ID:202001006984596558   Update date: Nov. 17, 2024

Naka Sadahiro

ナカ サダヒロ | Naka Sadahiro
Affiliation and department:
Research field  (1): Radiology
Research keywords  (4): 分析化学 ,  放射性医薬品 ,  薬学 ,  核医学
Research theme for competitive and other funds  (9):
  • 2024 - 2027 Development of innovative alpha therapy targeting cancer-associated fibroblasts
  • 2023 - 2027 がん間質FAPI PETイメージングにおける集積の生物学的背景と臨床的意義の解明
  • 2022 - 2025 Developing of radiolabeling method and Investigation of in vivo pharmacokinetics of BSH using in BNCT
  • 2019 - 2022 Development of Nuclear Medicine Therapy targeting Cancer Stroma
  • 2017 - 2021 Construction of a disposable synthesis system for F-18 labeled tracers by solid phase extraction method
Show all
Papers (97):
  • Kaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Sadahiro Naka, Kazuhiro Ooe, Atsushi Toyoshima, Frederik Giesel, Takeshi Usui, et al. Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. International journal of molecular sciences. 2024. 25. 21
  • Takashi Kamiya, Sadahiro Naka, Tadashi Watabe, Keiko Matsunaga, Kayako Isohashi, Hidetaka Sasaki, Keita Okamura, Kana Iwao, Isamu Yabata, Mitsuaki Tatsumi, et al. Abnormal localized [18F]FDG accumulation in a Hoffman 3D brain phantom caused by Pseudomonas aeruginosa and Stenotrophomonas maltophilia. European journal of nuclear medicine and molecular imaging. 2024
  • Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, et al. Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry. 2024. 9. 1. 29-29
  • Tadashi Watabe, Ivan Ray David, Toru Kimura, Takashi Hiroshima, Mitsuaki Tatsumi, Sadahiro Naka, Takashi Kamiya, Eriko Fukui, Takashi Kanou, Naoko Ose, et al. Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET. European Journal of Nuclear Medicine and Molecular Imaging. 2023
  • Tadashi Watabe, Kazuya Kabayama, Sadahiro Naka, Ryuku Yamamoto, Kazuko Kaneda, Satoshi Serada, Kazuhiro Ooe, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, et al. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with89Zr or211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma. Journal of Nuclear Medicine. 2023. jnumed.123.266313-jnumed.123.266313
more...
MISC (63):
more...
Work history (2):
  • 2022/04 - 現在 大阪大学医学部附属病院 薬剤部 薬剤師
  • 2010/04 - 2022/03 Osaka University Hospital
Awards (1):
  • 2022/06 - Poster Award (Third Place) - Molecular Targeting Probes-Radioactive & Nonradioactive 米国核医学会
Association Membership(s) (3):
日本病院薬剤師会 ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  JAPANESE SOCIETY OF NUCLEAR MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page